Steensma, D P <br/><br/>
Clarifications to the standard neutrophil response criteria for clinical trials in myelodysplastic syndromes are needed.  [electronic resource] 

 -  Blood  May 2001 
 - 3321-2 p.  digital 
<br/><br/> Publication Type: Comment; Letter 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood.v97.10.3321  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Clinical Trials as Topic<br/>Humans<br/>Leukocyte Count<br/>Myelodysplastic Syndromes--blood<br/>Neutrophils